Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Not applicableStudy completedNCT05612880What this trial is testingPhysical Function During ARSI TreatmentWho this might be right forAdvanced Prostate Carcinoma UNC Lineberger Comprehensive Cancer Center 24
Not applicableUnknownNCT00264056What this trial is testingEfficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue MetastasesWho this might be right forAdvanced Metastastic Malignant MelanomaRefractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases Fachklinik Hornheide an der Universität Münster 26
Testing effectiveness (Phase 2)Study completedNCT00054145What this trial is testingPerifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast CancerWho this might be right forBreast Cancer University Health Network, Toronto
Testing effectiveness (Phase 2)Temporarily pausedNCT07042295What this trial is testingTreatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune SystemWho this might be right forLocally Recurrent Skin Squamous Cell CarcinomaMetastatic Skin Squamous Cell Carcinoma National Cancer Institute (NCI) 86
Not applicableStudy completedNCT02088775What this trial is testingPET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerMetastatic Extrahepatic Bile Duct Cancer+4 more Fox Chase Cancer Center 44
Large-scale testing (Phase 3)Active Not RecruitingNCT06316531What this trial is testingA Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast CancerWho this might be right forHER2-positive Breast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 274
Not applicableStudy completedNCT01935102What this trial is testingPolymorphism Interaction to Predict Bevacizumab EfficacyWho this might be right forMetastatic Breast Cancer University of Pisa 169
Not applicableLooking for participantsNCT06902545What this trial is testingObserve the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.Who this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Korea, Inc.
Early research (Phase 1)Looking for participantsNCT05003895What this trial is testingGPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor MalignanciesWho this might be right forHepatocellular CarcinomaHepatocellular CancerMetastatic Hepatocellular Carcinoma National Cancer Institute (NCI) 38
Not applicableStudy completedNCT02156895What this trial is testingPost Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South KoreaWho this might be right forAdvanced Renal Cell Carcinoma Pfizer 111
Testing effectiveness (Phase 2)Ended earlyNCT04251169What this trial is testingPembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor ProgressionWho this might be right forMetastatic Breast Cancer SOLTI Breast Cancer Research Group 20
Testing effectiveness (Phase 2)WithdrawnNCT00311545What this trial is testingS0351, CNTO 328 in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer SWOG Cancer Research Network
Testing effectiveness (Phase 2)UnknownNCT04718701What this trial is testingAnlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic CancerWho this might be right forPancreatic NeoplasmMetastatic Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma The First Affiliated Hospital with Nanjing Medical University 53
Early research (Phase 1)Study completedNCT03641586What this trial is testingThe Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid TumorWho this might be right forSolid Tumors BeiGene 42
Early research (Phase 1)Study completedNCT01576666What this trial is testingPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsWho this might be right forDose EscalationSafetyPreliminary Efficacy+9 more Novartis Pharmaceuticals 120
Early research (Phase 1)Study completedNCT03260322What this trial is testingA Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Astellas Pharma Global Development, Inc. 169
Early research (Phase 1)Active Not RecruitingNCT03860272What this trial is testingFc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerWho this might be right forAdvanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more Agenus Inc. 499
Early research (Phase 1)Ended earlyNCT03166631What this trial is testingA Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have SpreadWho this might be right forNeoplasmsNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 62
Early research (Phase 1)Active Not RecruitingNCT04648202What this trial is testingFS120 Phase 1/1b Study in Patients With Advanced MalignanciesWho this might be right forAdvanced CancerMetastatic Cancer invoX Pharma Limited 82